KaloBios Pharmaceuticals, Inc. recently announced data on a Phase 2 randomized double-blind, placebo-controlled trial of KB001-A, an anti-PcrV monoclonal…
Articles by Daniela Semedo, PhD
A new study entitled “Pulsed direct and constant direct currents in the pilocarpine iontophoresis sweat chloride test,” recently published…
Galapagos is a company specializing in novel mechanisms of small-molecule and antibody programs for cystic fibrosis. In a recent…
A new study from a team of researchers of the University of Pittsburgh Center for Vaccine Research (CVR), entitled…
A new study published in the Orphanet Journal of Rare Diseases, presented the effectiveness of Cysteamine for the…
In the United Kingdom, The Cystic Fibrosis Trust along with the children’s charity Action Medical Research, are funding…